World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
94
Citations
86533
World Ranking
10226
National Ranking
5259

Richard C. Mohs publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Richard C. Mohs sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 379 publications — 34th percentile

34% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Richard C. Mohs D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Richard C. Mohs sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 94 D-Index — 49th percentile

49% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Richard C. Mohs is affiliated with Eli Lilly in the United States and has contributed extensively to research in medicine, with a focus on dementia, cognitive impairment, and Alzheimer's disease. Their body of work spans various subfields including psychiatry and mental health, physiology, economics and econometrics, pharmacology, and neurology.

Their research primarily covers topics such as dementia and cognitive impairment research, Alzheimer's disease research and treatments, cholinesterase and neurodegenerative diseases, health systems, economic evaluations, quality of life, pharmaceutical economics and policy, statistical methods in clinical trials, and frailty in older adults.

Mohs has published in a range of scientific venues, with notable frequency in the following journals:

  • Alzheimer's & Dementia
  • Alzheimer's & Dementia Translational Research & Clinical Interventions
  • Journal of Alzheimer's Disease
  • Neurology
  • Nature Aging

Among the recent papers authored or co-authored by Mohs are:

  • The Bio-Hermes Study: Biomarker database developed to investigate blood-based and digital biomarkers in community-based, diverse populations clinically screened for Alzheimer's disease (2024, Alzheimer's & Dementia)
  • The HOPE4MCI study: A randomized double-blind assessment of AGB101 for the treatment of MCI due to AD (2024, Alzheimer's & Dementia Translational Research & Clinical Interventions)
  • CERAD (Consortium to Establish a Registry for Alzheimer's Disease) Neuropsychology Assessment Battery: 35 Years and Counting (2023, Journal of Alzheimer's Disease)
  • Challenges and progress in research, diagnostics, and therapeutics in Alzheimer's disease and related dementias (2022, Alzheimer's & Dementia Translational Research & Clinical Interventions)
  • Value-Generating Exploratory Trials in Neurodegenerative Dementias (2021, Neurology)

Frequent collaborators in Mohs's work include John Dwyer, Jason Bork, Michela Gallagher, Douglas W. Beauregard, and Diana Kerwin, reflecting ongoing partnerships across multiple studies in the field.

Best Publications

  • The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease

    Guy M. McKhann;Guy M. McKhann;David S. Knopman;Howard Chertkow;Bradley T. Hyman

  • Current concepts in mild cognitive impairment.

    Ronald C. Petersen;Rachelle Doody;Alexander Kurz;Richard C. Mohs

  • The consortium to establish a registry for alzheimer’s disease (CERAD). Part I. Clinical and neuropsychological assessment of alzheimer’s disease

    J. C. Morris;A. Heyman;R. C. Mohs;J. P. Hughes

  • A new rating scale for Alzheimer's disease.

    Wilma G. Rosen;Richard C. Mohs;Kenneth L. Davis

  • The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

    G.M. McKhann;D.S. Knopman;H. Chertkow;B.T. Hyman

  • A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease

    S. L. Rogers;M. R. Farlow;R. S. Doody;R. Mohs

  • Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease

    RS Rachelle S. Doody;RG Ronald G. Rg Thomas;Martin Farlow;Takeshi Iwatsubo

  • Correlation Between Elevated Levels of Amyloid β-Peptide in the Brain and Cognitive Decline

    Jan Näslund;Vahram Haroutunian;Richard Mohs;Kenneth L. Davis

  • Serotonergic Studies in Patients with Affective and Personality Disorders: Correlates with Suicidal and Impulsive Aggressive Behavior

    Emil F. Coccaro;Larry J. Siever;Howard M. Klar;Gail Maurer

  • A Phase 3 Trial of Semagacestat for Treatment of Alzheimer's Disease

    Rachelle S. Doody;Rema Raman;Martin Farlow;Takeshi Iwatsubo

  • Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials.

    Michael Grundman;Ronald C. Petersen;Steven H. Ferris;Ronald G. Thomas

  • The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part V. A normative study of the neuropsychological battery

    Kathleen A. Welsh;Nelson Butters;Richard C. Mohs;D. Beekly

  • Detection of Abnormal Memory Decline in Mild Cases of Alzheimer's Disease Using CERAD Neuropsychological Measures

    Kathleen Welsh;Nelson Butters;James Hughes;Richard Mohs

  • Donepezil Improves Cognition and Global Function in Alzheimer Disease A 15-Week, Double-blind, Placebo-Controlled Study

    Sharon L. Rogers;Rachelle S. Doody;Richard C. Mohs;Lawrence T. Friedhoff

  • Development of cognitive instruments for use in clinical trials of antidementia drugs: Additions to the Alzheimer's Disease Assessment Scale that broaden its scope.

    Richard C. Mohs;David Knopman;Ronald C. Petersen;Steven H. Ferris

  • High, usual and impaired functioning in community-dwelling older men and women: Findings from the MacArthur Foundation Research Network on successful aging

    Lisa F. Berkman;Teresa E. Seeman;Marilyn Albert;Dan Blazer

  • Detection and staging of dementia in Alzheimer's disease. Use of the neuropsychological measures developed for the Consortium to Establish a Registry for Alzheimer's Disease

    Kathleen A. Welsh;Nelson Butters;James P. Hughes;Richard C. Mohs

  • Cholinergic markers in elderly patients with early signs of Alzheimer disease.

    Kenneth L. Davis;Richard C. Mohs;Deborah Marin;Dushyant P. Purohit

  • A 1-year, placebo-controlled preservation of function survival study of donepezil in AD patients

    Richard C. Mohs;R. S. Doody;J. C. Morris;J. R. Ieni

  • The Consortium to Establish a Registry for Alzheimer's Disease (CERAD).: Part XI. Clinical milestones in patients with Alzheimer's disease followed over 3 years

    D. Galasko;S.D. Edland;J. C. Morris;C. Clark

Frequent Co-Authors

Kenneth L. Davis
Kenneth L. Davis Icahn School of Medicine at Mount Sinai
Jeremy M. Silverman
Jeremy M. Silverman Icahn School of Medicine at Mount Sinai
Philip D. Harvey
Philip D. Harvey University of Miami
Larry J. Siever
Larry J. Siever Icahn School of Medicine at Mount Sinai
Richard S.E. Keefe
Richard S.E. Keefe Duke University
Paul S. Aisen
Paul S. Aisen University of Southern California
Vahram Haroutunian
Vahram Haroutunian Icahn School of Medicine at Mount Sinai
Michael H. Davidson
Michael H. Davidson University of Chicago
James Schmeidler
James Schmeidler Icahn School of Medicine at Mount Sinai
Rachelle S. Doody
Rachelle S. Doody Roche (Switzerland)

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re exploring career options related to medicine, there are several in-demand online health degrees that offer flexibility and affordability. Earning a graduate degree in healthcare is a powerful way to expand your professional opportunities, whether you are interested in clinical practice, healthcare leadership, or specialized roles.

For those inclined toward management, the cheapest online master degree in healthcare administration can help you move into key administrative positions at hospitals and clinics. If your goal is advanced clinical practice, consider cheap online dnp programs, which focus on developing clinical leadership and nurse practitioner skills.

Pharmacists are also in high demand, and the best online pharmacy school options allow you to earn your PharmD with greater convenience. If you’re interested in the technology side of health, online rhit degree programs prepare you for roles in managing electronic health data.

Online degrees in healthcare are becoming more reputable and affordable, making it easier for students to chart specialized career pathways that align with their interests and professional goals.

Best Scientists Citing Richard C. Mohs

Trending Scientists

Recently Published Articles